Susan M. Wade - Concepedia

Concepedia

Author

Susan M. Wade

University of Michigan

Also Known As

S M Wade, S. M. Wade, Susan M Wade, Susan M. Wade, Susan Wade

41

Publications

1.2K

Citations

20

H-Index

60

Concepts

All Affiliations

University of Michigan Michigan State University RIKEN Center for Brain Science

SM

About

Susan M. Wade is an author at University of Michigan specializing in medicine, signal transduction, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	551
2	Health Sciences	2	2	43
3	Social Sciences	2	2	93
4	Engineering	1	1	17
5	Natural Sciences	1	1	131

Susan M. Wade

×

24

Publications

1.2K

Citations

20

H-Index

	Year	Citations
CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling Chris R. Evelyn, Susan M. Wade, Qin Wang, Molecular Cancer Therapeutics	2007	200
A Spatial Focusing Model for G Protein Signals Huailing Zhong, Susan M. Wade, Peter Woolf, Journal of Biological Chemistry Biophysical ModelingSignal RecognitionChemical BiologyProtein FoldingCell Signaling	2003	131
Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents Jessica L. Bell, Andrew J. Haak, Susan M. Wade, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetingRho/mkl1/srf Transcriptional PathwayMedicineTumor Targeting	2013	68
G<sub>i</sub>Activator Region of α<sub>2A</sub>-Adrenergic Receptors: Distinct Basic Residues Mediate G<sub>i</sub>versus G<sub>s</sub>Activation Susan M. Wade, William K. Lim, Keng‐Hsin Lan, Molecular Pharmacology	1999	66
Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423 Chris R. Evelyn, Jessica L. Bell, Jenny G. Ryu, Bioorganic & Medicinal Chemistry Letters MedicinePharmacologyAnti-cancer AgentTumor SuppressorProstatic Disease	2009	66
Phase-Locked Signals Elucidate Circuit Architecture of an Oscillatory Pathway Andreja Jović, Bryan Lad Howell, Michelle Cote, PLoS Computational Biology Phase-locking AnalysisNeurotransmitterSynthetic CircuitNeurotransmissionOscillatory Pathway	2010	56
Mutagenesis and peptide analysis of the DRY motif in the α2A adrenergic receptor: evidence for alternate mechanisms in G protein-coupled receptors Duane A. Chung, Susan M. Wade, Carol B. Fowler, Biochemical and Biophysical Research Communications α2A Adrenergic ReceptorMolecular PharmacologyDry MotifMolecular PhysiologySignal Transduction	2002	55
Inverse Agonist Activity at the α<sub>2A</sub>-Adrenergic Receptor Susan M. Wade, Keng-Li Lan, Dorian J. Moore, Molecular Pharmacology	2001	49
Selectivity and Anti-Parkinson’s Potential of Thiadiazolidinone RGS4 Inhibitors Levi L. Blazer, Andrew J. Storaska, Emily M. Jutkiewicz, ACS Chemical Neuroscience	2015	48
Structural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region. Susan M. Wade, Mary K. Scribner, Hiroko Mori Dalman, Molecular Pharmacology	1996	46

Page 1